Barton, United Kingdom

Jörg Schneider


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jörg Schneider: Innovator in Vaccination Technologies

Introduction

Jörg Schneider is a notable inventor based in Barton, GB, recognized for his significant contributions to the field of immunology and vaccination. With one patent to his name, Schneider has focused on developing innovative methods and reagents aimed at enhancing immune responses, specifically targeting CD8 T cells, which are vital for combating various diseases.

Latest Patents

Schneider's patent, titled "Methods and reagents for vaccination which generate a CD8 T cell immune response," describes novel techniques for immunization against malaria and other antigens, including those associated with viral and tumor cells. The patent presents a unique vaccination regimen that combines a priming composition with a boosting composition. This boosting composition utilizes a non-replicating or replication-impaired pox virus vector, which carries at least one CD8 T cell epitope that is also found in the priming composition. This innovative approach aims to enhance the immune response, providing a more effective vaccination strategy.

Career Highlights

Jörg Schneider is associated with Oxxon Pharmaccines Ltd., where his work continues to impact the field of vaccine development. Through his extensive research, Schneider has made strides in creating effective immunological responses that are essential for addressing emerging infectious diseases and immune-related conditions.

Collaborations

Throughout his career, Schneider has collaborated with esteemed colleagues such as Andrew James McMichael and Adrian V S Hill. These partnerships have fostered significant advancements in immunology and contributed to the progress of vaccination methodologies, further establishing Schneider's reputation as a valuable inventor in the scientific community.

Conclusion

Jörg Schneider's work represents a significant advancement in vaccination technology, focusing on creating robust immune responses against critical health threats. His innovative patent reflects his commitment to improving public health through scientific ingenuity and collaboration with other experts in the field. As research continues, Schneider's contributions are poised to play a pivotal role in the future of immunization strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…